ARTICLE | Clinical News
Ibrutinib regulatory update
May 21, 2012 7:00 AM UTC
Pharmacyclics disclosed in its 3Q12 earnings that FDA granted Orphan Drug designation for ibrutinib to treat chronic lymphocytic leukemia (CLL). The Bruton's tyrosine kinase (Btk) inhibitor that cova...